CIK 0000711377
- Large accelerated filer
NEOGEN CORP
Sign in to watch- Ticker
- NEOG
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- May 31
- Incorporated
- MI
- Entity type
- Operating
- EIN
- 382367843
- Phone
- +1 517-372-9200
- Business address
- 620 LESHER PLACE, LANSING, MI, 48912
- Open-market buys, last 90 days
- $6,035
- in 1 filing
- Open-market sales, last 90 days
- $114,676
- in 1 filing
Net −$108,641. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-04-23 | ADENT JOHN EDWARD CEO | Other acquisition | +17,899 | $11.81 | $211K | 170,288 |
| 2024-04-23 | ADENT JOHN EDWARD CEO | Other acquisition | +17,477 | $12.09 | $211K | 169,866 |
| 2024-04-17 | Jones Douglas Edward Chief Operating Officer | Purchase | +10,000 | $12.36 | $124K | 46,131 |
| 2024-04-11 | BOREL JAMES C Director | Purchase | +7,500 | $13.06 | $98K | 21,392 |
| 2024-04-10 | Naemura David H. CFO | Purchase | +12,500 | $12.51 | $156K | 30,040 |
| 2024-04-10 | ADENT JOHN EDWARD CEO | Purchase | +23,000 | $12.36 | $284K | 152,389 |
| 2023-11-03 | BOEHM WILLIAM T Director | Purchase | +2,000 | $16.06 | $32K | 26,509 |
| 2023-10-26 | Naemura David H. CFO | Grant or award · Common Stock (Right to Buy) | +179,550 | 559,297 | ||
| 2023-10-26 | Naemura David H. CFO | Grant or award · Common Stock (Right to Buy) | +379,747 | 559,297 | ||
| 2023-10-26 | Naemura David H. CFO | Grant or award · Restricted Stock Units | +46,512 | 85,247 | ||
| 2023-10-26 | Woteki Catherine E Director | Option exercise · Common Stock (Right to Buy) | +13,716 | 38,883 | ||
| 2023-10-26 | Woteki Catherine E Director | Option exercise · Restricted Stock Units | +5,329 | 9,706 | ||
| 2023-10-26 | Tobin James P Director | Option exercise · Common Stock (Right to Buy) | +13,716 | 66,217 | ||
| 2023-10-26 | Tobin James P Director | Option exercise · Restricted Stock Units | +5,329 | 9,706 | ||
| 2023-10-26 | RODRIGUEZ RAFAEL A Director | Option exercise · Common Stock (Right to Buy) | +13,716 | 38,883 | ||
| 2023-10-26 | RODRIGUEZ RAFAEL A Director | Option exercise · Restricted Stock Units | +5,329 | 9,706 | ||
| 2023-10-26 | Gupta Aashima Director | Option exercise · Common Stock (Right to Buy) | +13,716 | 32,132 | ||
| 2023-10-26 | Gupta Aashima Director | Option exercise · Restricted Stock Units | +5,329 | 9,470 | ||
| 2023-10-26 | Green Ronald D Director | Option exercise · Common Stock (Right to Buy) | +13,716 | 70,663 | ||
| 2023-10-26 | Green Ronald D Director | Option exercise · Restricted Stock Units | +5,329 | 9,706 |
Page 18 of 21 · 414 trades